Dyslipidaemia in African Americans, Hispanics and Whites with type 2 diabetes mellitus and hypertension

被引:21
|
作者
Sharma, MD
Pavlik, VN
机构
[1] Baylor Coll Med, Dept Med, Div Endocrinol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA
来源
DIABETES OBESITY & METABOLISM | 2001年 / 3卷 / 01期
关键词
dyslipidaemia in type 2 diabetes mellitus; hypertension; ethnicity;
D O I
10.1046/j.1463-1326.2001.00113.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To study the pattern of dyslipidaemia in African American, Hispanic, and White patients with type 2 diabetes mellitus and/or hypertension. Methods: The data were collected retrospectively on 6450 patients followed in the Harris County Hospital District Community Clinics. The information collected from review of the charts included each patient's age, sex, race, body mass index (b.m.i.), duration of type 2 diabetes mellitus and hypertension, medications, fasting plasma glucose, haemoglobin A(1)c, and fasting lipid profile. Mean lipid and haemoglobin A(1)c levels in the three ethnic groups were compared. The risk of abnormal cholesterol and triglyceride levels was assessed with logistic regression analysis. Results: The results show that in patients with type 2 diabetes mellitus after correcting for age, sex and b.m.i., African Americans have the lowest serum triglyceride concentrations and Whites have the highest values. This trend holds true even in patients with hypertension and in patients with both hypertension and type 2 diabetes mellitus. The risk of having abnormal triglycerides is 74% lower in African Americans, and 42% lower in Hispanics than Whites based on logistic regression model. Despite better glycaemic control, Whites have a greater increase in serum triglyceride concentrations than Hispanics and African Americans. Conclusions: Although African Americans are known to be at higher risk for cardiovascular complications than Whites or Hispanics, they appear to have lower triglyceride concentrations than Whites or Hispanics in the presence of type 2 diabetes mellitus. This suggests that an increased prevalence of other adverse factors must contribute to their heightened cardiovascular risk.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 50 条
  • [21] Targeting Nocturnal Hypertension in Type 2 Diabetes Mellitus
    Rossen, Niklas Blach
    Knudsen, Soren Tang
    Fleischer, Jesper
    Hvas, Anne-Mette
    Ebbehoj, Eva
    Poulsen, Per Logstrup
    Hansen, Klavs Wurgler
    HYPERTENSION, 2014, 64 (05) : 1080 - +
  • [22] Management of hypertension in patients with type 2 diabetes mellitus
    Mashitisho, M. L., I
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (01) : 41 - 44
  • [23] Cerebral White Matter Hyperintensity in African Americans and European Americans with Type 2 Diabetes
    Divers, Jasmin
    Hugenschmidt, Christina
    Sink, Kaycee M.
    Williamson, Jeffrey D.
    Ge, Yaorong
    Smith, S. Carrie
    Bowden, Donald W.
    Whitlow, Christopher T.
    Lyders, Eric
    Maldjian, Joseph A.
    Freedman, Barry I.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07): : E46 - E52
  • [24] Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes
    Sellers M.B.
    Divers J.
    Lu L.
    Xu J.
    Smith S.C.
    Bowden D.W.
    Herrington D.
    Freedman B.I.
    Soliman E.Z.
    Journal of Epidemiology and Global Health, 2014, 4 (4) : 289 - 296
  • [25] Type 2 Diabetes and Cognitive Decline Over 14 Years in Middle-Aged African Americans and Whites: The ARIC Brain MRI Study
    Mayeda, Elizabeth R.
    Haan, Mary N.
    Neuhaus, John
    Yaffe, Kristine
    Knopman, David S.
    Sharrett, A. Richey
    Griswold, Michael E.
    Mosley, Thomas H.
    NEUROEPIDEMIOLOGY, 2014, 43 (3-4) : 220 - 227
  • [26] Hypertension and related risk factors in type 2 diabetes mellitus
    Lunetta, M
    Barbagallo, A
    Crimi, S
    Di Mauro, M
    Sangiorgio, L
    Mughini, L
    PANMINERVA MEDICA, 1998, 40 (03) : 169 - 173
  • [27] CARDIAC REMODELING IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION
    Krutikov, Ye S.
    Tsvetkov, V. A.
    Chistyakova, S., I
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 4 - 9
  • [28] Hypertension in patients with type 2 diabetes mellitus: Targets and management
    Pavlou, Dimitra, I
    Paschou, Stavroula A.
    Anagnostis, Panagiotis
    Spartalis, Michael
    Spartalis, Eleftherios
    Vryonidou, Andromachi
    Tentolouris, Nicholas
    Siasos, Gerasimos
    MATURITAS, 2018, 112 : 71 - 77
  • [29] Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites
    Shulman, Eric
    Chudow, Jay J.
    Essien, Utibe R.
    Shanbhag, Anusha
    Kargoli, Faraj
    Romero, Jorge
    Di Biase, Luigi
    Fisher, John
    Krumerman, Andrew
    Ferrick, Kevin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 : 89 - 94
  • [30] Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus
    Prakoso, Agung Tri
    Wahyono, Tri Yunis Miko
    Sibarani, Roy Panusunan
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 843 - 847